U.S. Physical Therapy (NYSE:USPH – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported $0.51 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.58 by ($0.07), Briefing.com reports. U.S. Physical Therapy had a net margin of 4.67% and a return on equity of 8.52%. The company had revenue of $155.70 million during the quarter, compared to analysts’ expectations of $153.30 million. During the same quarter in the prior year, the company earned $0.59 earnings per share. The firm’s revenue was up 4.8% compared to the same quarter last year.
U.S. Physical Therapy Trading Down 2.5 %
NYSE:USPH traded down $2.68 on Wednesday, hitting $102.91. 35,113 shares of the stock were exchanged, compared to its average volume of 68,376. The stock has a market cap of $1.55 billion, a PE ratio of 76.52, a PEG ratio of 4.99 and a beta of 1.39. The company has a current ratio of 2.28, a quick ratio of 2.28 and a debt-to-equity ratio of 0.29. The stock has a fifty day moving average of $105.26 and a 200-day moving average of $96.31. U.S. Physical Therapy has a fifty-two week low of $78.08 and a fifty-two week high of $124.11.
U.S. Physical Therapy Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, April 5th. Shareholders of record on Tuesday, March 12th were paid a dividend of $0.44 per share. The ex-dividend date of this dividend was Monday, March 11th. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.43. This represents a $1.76 annualized dividend and a yield of 1.71%. U.S. Physical Therapy’s dividend payout ratio is currently 130.37%.
Insider Activity
Wall Street Analysts Forecast Growth
USPH has been the topic of several recent research reports. Barrington Research upped their price objective on U.S. Physical Therapy from $120.00 to $122.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. JPMorgan Chase & Co. increased their target price on U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 13th. Finally, StockNews.com upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Monday, March 18th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $125.67.
View Our Latest Report on U.S. Physical Therapy
About U.S. Physical Therapy
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Further Reading
- Five stocks we like better than U.S. Physical Therapy
- How to Calculate Inflation Rate
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- Upcoming IPO Stock Lockup Period, Explained
- Generac Powers Ahead on the Electrification Mega-Trend
- How to invest in marijuana stocks in 7 stepsÂ
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.